When biomarkers aren't an option in vaccine research, we need a well-supported alternative
NIDA has launched a $100,000 competition to encourage startup companies
Sitting Down With… Robert A. Weinberg, founding member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology, USA.
As cancer rates continue to climb, low and middle income countries are ramping up prevention and screening efforts.
When it comes to industry–academia partnerships, it’s quality – not quantity – that counts.
Sitting Down With… Thomas Mellman, Professor and Director, Center for Clinical and Translational Research and Stress/Sleep Studies Program, Howard University College of Medicine, Washington, DC, USA.
The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.
Ebola and Zika have helped normalize data sharing, but there are still many obstacles to overcome.
Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.
Sitting Down With…John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.